Emerging Vaccine-Breakthrough SARS-CoV-2 Variants.

Journal Information

Full Title: ACS Infect Dis

Abbreviation: ACS Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the detailed descriptions of data set and machine learning model are found in the literature and are available at topnetmab ( https://github com/weilabmsu/topnetmab accessed august 5 2021). 4 files are in this folder; (s2 1 1) antibodies_disruptmutation csv"

Evidence found in paper:

"the detailed descriptions of data set and machine learning model are found in the literature and are available at topnetmab ( https://github com/weilabmsu/topnetmab accessed august 5 2021).; the topnettree model is available at topnetmab ( https://github com/weilabmsu/topnetmab accessed august 5 2021)."

Evidence found in paper:

"The authors declare no competing financial interest."

Evidence found in paper:

"This work was supported in part by NIH Grant GM126189, NSF Grants DMS-2052983, DMS-1761320, and IIS-1900473, NASA Grant 80NSSC21M0023, Michigan Economic Development Corporation, MSU Foundation, Bristol-Myers Squibb 65109, and Pfizer. G.W.W. thanks the discussion with Dr. Peter Lyster which inspired this work."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025